Cancer sequencing unravels clonal evolution (original) (raw)
- News & Views
- Published: 07 May 2012
Nature Biotechnology volume 30, pages 408–410 (2012) Cite this article
- 7200 Accesses
- 42 Citations
- 2 Altmetric
- Metrics details
Subjects
Characterization of tumor heterogeneity at the sequence level presents new challenges and opportunities for targeted therapies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Figure 1: Clonal evolution in primary tumors and metastases (adapted from ref. 1).

The alternative text for this image may have been generated using AI.
References
- Nowell, P.C. Science 194, 23–28 (1976).
Article CAS Google Scholar - Hou, Y. et al. Cell 148, 873–885 (2012).
Article CAS Google Scholar - Xu, X. et al. Cell 148, 886–895 (2012).
Article CAS Google Scholar - Gerlinger, M. et al. N. Engl. J. Med. 366, 883–892 (2012).
Article CAS Google Scholar - Navin, N. et al. Nature 472, 90–94 (2011).
Article CAS Google Scholar - Anderson, K. et al. Nature 469, 356–361 (2011).
Article CAS Google Scholar - Shah, S.P. et al. Nature 461, 809–813 (2009).
Article CAS Google Scholar - Yachida, S. et al. Nature 467, 1114–1117 (2010).
Article CAS Google Scholar - Campbell, P.J. et al. Nature 467, 1109–1113 (2010).
Article CAS Google Scholar - Shah, S.P. et al. Nature 10.1038/nature10933 (2012).
Author information
Authors and Affiliations
- Carlos Caldas is in the Department of Oncology at the University of Cambridge and at Cancer Research UK, Cambridge Research Institute, Cambridge, UK.,
Carlos Caldas
Corresponding author
Correspondence toCarlos Caldas.
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Caldas, C. Cancer sequencing unravels clonal evolution.Nat Biotechnol 30, 408–410 (2012). https://doi.org/10.1038/nbt.2213
- Published: 07 May 2012
- Issue date: May 2012
- DOI: https://doi.org/10.1038/nbt.2213